Clinical Trial Update: Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an everolimus-eluting stent for non-acute coronary occlusion has completed. The study involved patients with coronary artery d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Occlusion

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Raul Moreno | Conditions: Coronary Artery Disease, Coronary Occlusion | Phase 3 | Status: COMPLETED